GlobeNewswire Press Release
TRACY, Calif., March 19, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, is hosting a model home grand opening celebration at Regency at Tracy Lakes, a gated, master-planned community of 590 luxury homes for 55+ active-adults located in the expansive valleys of Tracy,…
PITTSBURGH, March 19, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in high-power diode lasers for aesthetic and dermatological applications, today introduced a game-changing diode laser bar for the hair removal industry. This innovative 808 nm bar employs a two-junction configuration to deliver 200 W of output with…
WEBSITE: https://greenwelltaylorcollection.premiersothebysrealty.com SARASOTA, Fla., March 19, 2024 (GLOBE NEWSWIRE) — Andrew Greenwell and Nikki Taylor announce the launch of the Greenwell & Taylor Collection. The real estate team will conduct its operations out of Premier Sotheby’s International Realty’s Downtown Sarasota office. The team details may be viewed here. Greenwell is…
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maplebear Inc. d/b/a Instacart (“Instacart” or the “Company”) (NASDAQ: CART) and reminds investors of the March 25, 2024 deadline to seek the role of lead plaintiff in…
Charleston, SC, March 19, 2024 (GLOBE NEWSWIRE) — The new memoir Life Beyond the Border: A Journey from Poverty to Passionate Purpose shares an inspiring story that traverses from the impoverished border town of Brownsville, Texas to the heights of entrepreneurial and personal success. Written by acclaimed business coach and…
Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for atopic dermatitis Orphan drug designation and new interim data from Phase 1/1b clinical trial further demonstrate soquelitinib’s potential to address the need for new treatments for PTCL Conference call today…
Data from first adult patient in REVEAL Phase 1/2 trial showed TSHA-102 (low dose, 5.7×1014 total vg) was well-tolerated with no treatment-emergent SAEs as of 35-week assessment, with sustained improvement across key efficacy measures at decreased steroid levels and new improvement in RSBQ at month six Data from second adult…
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL) and reminds investors of the April 15, 2024 deadline to seek the role of lead plaintiff in a federal…
Boston and New York, USA, March 19, 2024 (GLOBE NEWSWIRE) — Currently reaching over 400,000 young people, national nonprofit Peer Health Exchange (PHE) provides young people with the tools they need to make healthy decisions. The organization’s model includes three primary pillars: in-person health education on mental health, sexual health…
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and reminds investors of the April 23, 2024 deadline to seek the role of lead plaintiff in a federal…